outcomes

Open-Label Extension Data Confirms Sustained Benefit of Acoramidis on Cardiovascular Outcomes, Including Statistically Significant Reduction in ACM Within 36 Months

November 18, 2024 11:15 ET | Source: BridgeBio Pharma, Inc. - Acoramidis demonstrated the earliest known time to separation in…

1 month ago

CenTrak Appoints Steffi Thorlichen as Chief Customer Experience Officer to Enhance Healthcare Client Outcomes

NEWTOWN, Pa., Nov. 14, 2024 (GLOBE NEWSWIRE) -- CenTrak, the leader in Real-Time Location System (RTLS) solutions, proudly announces the…

1 month ago